24
staff
Kristin Schneeman
Kristin Schneeman joined FasterCures in April 2005, with primary responsibility for its innovatio
n portfolio of projects and activities.
+ Read More
panel
FasterCures Private Dinner (Invite only)
An intimate dinner for "friends of FasterCures," including our VIP delegation of the Advisory Bo
ard, Nonprofit Council, Business Council and TRAIN members.
+ Read More
panel
FasterCures Advisory Groups Meeting (Invite only)
This session will bring together the FasterCures Advisory Board, Business Council, Nonprofit Cou
ncil, and Senior Fellows. Programmatic updates will be discussed and upcoming key events will be flagged for the engagement of all groups.
+ Read More
panel
FasterCures Advisors Meeting: A Conversation with Meena Seshamani (Invite only)
This annual meeting brings together the FasterCures Advisory Groups, including the Board, Busine
ss Council, and Changemakers nonprofit advisory council, to discuss timely topics across the biomedical research ecosystem. Dr.
+ Read More
staff
Valerie Barton
Valerie Barton, M.A.
panel
FasterCures Private Meeting (Invite only)
panel
FasterCures Board Meeting (Invite only)
landing page
Accelerating Innovation
At FasterCures, we aim to speed the delivery of treatments to all patients by addressing barriers to
the development of new products, by leveraging patients’ data responsibly and delivering direct benefits from contributing the
+ Read More
landing page
Antimicrobial Resistance
Antimicrobial resistance (AMR) has been called the silent pandemic.
landing page
Building Nonprofit Capacity
Since FasterCures’ inception in 2003, we have emphasized the importance of putting patients at the c
enter of the biomedical research system.
+ Read More
landing page
Strengthening Global Health
With the COVID-19 pandemic continuing to have a profound effect on lives and livelihoods here and ar
ound the world, one of the questions asked most frequently is, “How can we prevent this from happening again?” FasterCures init
+ Read More
landing page
Improving the Research and Development Environment
The COVID-19 pandemic revealed significant gaps in our health-care system, including in our clinical
trial infrastructure.
+ Read More